JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

New Benzimidazole-Based Bipolar Hosts: Highly Efficient Phosphorescent and Thermally Activated Delayed Fluorescent Organic Light-Emitting Diodes Employing the Same Device Structure.

The rapid development of the thermally activated delayed fluorescence (TADF) emitters makes it necessary to produce new versatile host materials for both phosphorescent and TADF emitters. Three new bipolar host materials, 9,9'-(2'-(1H-benzimidazol-1-yl)-[1,1'-biphenyl]-3,5-diyl)bis(9H-carbazole) (o-mCPBI), 9,9'-(3'-(1H-benzimidazol-1-yl)-[1,1'-biphenyl]-3,5-diyl)bis(9H-carbazole) (m-mCPBI), and 9,9'-(4'-(1H-benzimidazol-1-yl)-[1,1'-biphenyl]-3,5-diyl)bis(9H-carbazole) (p-mCPBI), are designed and synthesized by integrating mCP with benzimidazole moiety via the ortho-, meta-, and para-positions of N-phenyl. The influence of different linking modes on the thermal, photophysical, electrochemical, and charge transport properties of the compounds is studied. By employing the same device structure except the emitting layer, the device performances of the blue, green, yellow, red, white phosphorescent and blue, green TADF organic light-emitting diodes (OLEDs) based on the three hosts are investigated. Among these three hosts, o-mCPBI exhibits the best device performance with external quantum efficiencies of over 20% for phosphorescent OLEDs and enhanced efficiencies for TADF devices. All these devices show relatively low efficiency roll-offs at high brightness. The versatility of the benzimidazole-based bipolar host o-mCPBI, such as an extremely high triplet energy level, suitable molecular orbital energy levels, improved thermal and charge transport properties, and excellent device performances for various colors, makes it a universal host material for highly efficient both phosphorescent and TADF OLEDs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app